- Home
- MPTI vs ALEC Comparison
MPTI vs ALEC Comparison
Compare MPTI & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPTI | ALEC |
|---|---|---|
| Founded | 1965 | 2013 |
| Country | United States | United States |
| Employees | N/A | 103 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.9M | 262.7M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MPTI | ALEC |
|---|---|---|
| Price | $63.91 | $2.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 24.3K | ★ 862.5K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $49,012,000.00 | $21,045,000.00 |
| Revenue This Year | $13.32 | N/A |
| Revenue Next Year | $10.56 | $45.24 |
| P/E Ratio | $38.02 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.22 | $0.87 |
| 52 Week High | $68.50 | $3.40 |
Technical Indicators
Market Signals| Indicator | MPTI | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 59.42 |
| Support Level | $60.65 | $2.30 |
| Resistance Level | $67.09 | $2.53 |
| Average True Range (ATR) | 2.93 | 0.20 |
| MACD | -0.36 | -0.00 |
| Stochastic Oscillator | 32.20 | 62.50 |
Price Performance
Historical ComparisonAbout MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.